Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Liver Diseases

  Free Subscription


10.04.2017

1 AJR Am J Roentgenol
1 Am J Gastroenterol
3 Biochem Biophys Res Commun
1 BMC Gastroenterol
7 Br J Surg
1 Cancer Res
1 Dig Dis Sci
2 Eur Radiol
8 Gastroenterology
1 Gut
6 Hepatology
1 J Gastroenterol
1 J Hepatol
1 J Pediatr Surg
2 Lancet Oncol
3 PLoS One
1 Radiology
11 Transplant Proc


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    AJR Am J Roentgenol

  1. SARWAR A, Esparaz AM, Tapper EB, Brook OR, et al
    Comparison of Vascular Plugs and Pushable Coils for Variceal Embolization After TIPS.
    AJR Am J Roentgenol. 2017;208:650-655.
    PubMed     Text format     Abstract available


    Am J Gastroenterol

  2. CHEN SC, Chao Y, Yang MH
    Complete Response to the Combination of Pembrolizumab and Sorafenib for Metastatic Hepatocellular Carcinoma: A Case Report.
    Am J Gastroenterol. 2017;112:659-660.
    PubMed     Text format    


    Biochem Biophys Res Commun

  3. ZHANG W, Chen B, Zhang Y, Li K, et al
    The anti-hepatocellular carcinoma cell activity by a novel mTOR kinase inhibitor CZ415.
    Biochem Biophys Res Commun. 2017 Mar 30. pii: S0006-291X(17)30633.
    PubMed     Text format     Abstract available

  4. HAGA Y, Kanda T, Nakamoto S, Nakamura M, et al
    Interferon induces interleukin 8 and bone marrow stromal cell antigen 2 expression, inhibiting the production of hepatitis B virus surface antigen from human hepatocytes.
    Biochem Biophys Res Commun. 2017 Mar 28. pii: S0006-291X(17)30627.
    PubMed     Text format     Abstract available

  5. WU Y, Liu ZG, Yang AH, Fu XS, et al
    Identification of ACTG2 functions as a promoter gene in hepatocellular carcinoma cells migration and tumor metastasis.
    Biochem Biophys Res Commun. 2017 Apr 3. pii: S0006-291X(17)30664.
    PubMed     Text format     Abstract available


    BMC Gastroenterol

  6. BANG CS, Song IH
    Impact of antiviral therapy on hepatocellular carcinoma and mortality in patients with chronic hepatitis C: systematic review and meta-analysis.
    BMC Gastroenterol. 2017;17:46.
    PubMed     Text format     Abstract available


    Br J Surg

  7. MCCARTAN DP, Prichard RS, MacDermott RJ, Rothwell J, et al
    Role of bone scan in addition to CT in patients with breast cancer selected for systemic staging.
    Br J Surg. 2016;103:839-44.
    PubMed     Text format     Abstract available

  8. MARGONIS GA, Amini N, Buettner S, Besharati S, et al
    Impact of early postoperative platelet count on volumetric liver gain and perioperative outcomes after major liver resection.
    Br J Surg. 2016;103:899-907.
    PubMed     Text format     Abstract available

  9. PHILIPS P, Groeschl RT, Hanna EM, Swan RZ, et al
    Single-stage resection and microwave ablation for bilobar colorectal liver metastases.
    Br J Surg. 2016;103:1048-54.
    PubMed     Text format     Abstract available

  10. HOF J, Wertenbroek MW, Peeters PM, Widder J, et al
    Outcomes after resection and/or radiofrequency ablation for recurrence after treatment of colorectal liver metastases.
    Br J Surg. 2016;103:1055-62.
    PubMed     Text format     Abstract available

  11. ICHIDA A, Hasegawa K, Takayama T, Kudo H, et al
    Randomized clinical trial comparing two vessel-sealing devices with crush clamping during liver transection.
    Br J Surg. 2016;103:1795-1803.
    PubMed     Text format     Abstract available

  12. DASKALAKIS K, Karakatsanis A, Stalberg P, Norlen O, et al
    Clinical signs of fibrosis in small intestinal neuroendocrine tumours.
    Br J Surg. 2017;104:69-75.
    PubMed     Text format     Abstract available

  13. BERTUZZO VR, Giannella M, Cucchetti A, Pinna AD, et al
    Impact of preoperative infection on outcome after liver transplantation.
    Br J Surg. 2017;104:e172-e181.
    PubMed     Text format     Abstract available


    Cancer Res

  14. YUE F, Li W, Zou J, Jiang X, et al
    Spermidine prolongs lifespan and prevents liver fibrosis and hepatocellular carcinoma by activating MAP1S-mediated autophagy.
    Cancer Res. 2017 Apr 6. pii: canres.3462.2016.
    PubMed     Text format     Abstract available


    Dig Dis Sci

  15. YOSHIDA T, Akiba J, Matsui T, Nakamura K, et al
    Pigment Epithelium-Derived Factor (PEDF) Prevents Hepatic Fat Storage, Inflammation, and Fibrosis in Dietary Steatohepatitis of Mice.
    Dig Dis Sci. 2017 Apr 1. doi: 10.1007/s10620-017-4550.
    PubMed     Text format     Abstract available


    Eur Radiol

  16. WOO JH, Song KD, Kim SH
    Subcentimeter hypervascular nodules with typical imaging findings of hepatocellular carcinoma on gadoxetic acid-enhanced MRI: Outcomes of early treatment and watchful waiting.
    Eur Radiol. 2017 Apr 6. doi: 10.1007/s00330-017-4818.
    PubMed     Text format     Abstract available

  17. HERATH NI, Devun F, Herbette A, Lienafa MC, et al
    Potentiation of doxorubicin efficacy in hepatocellular carcinoma by the DNA repair inhibitor DT01 in preclinical models.
    Eur Radiol. 2017 Apr 3. doi: 10.1007/s00330-017-4792.
    PubMed     Text format     Abstract available


    Gastroenterology

  18. HOWELL J, Thompson AJ
    Hepatocellular Carcinoma After Sustained Virologic Response: Leave No One Behind.
    Gastroenterology. 2017 Mar 28. pii: S0016-5085(17)30334.
    PubMed     Text format    

  19. ZHANG W, He H, Zang M, Wu Q, et al
    Genetic Features of Aflatoxin-associated Hepatocellular Carcinomas.
    Gastroenterology. 2017 Mar 28. pii: S0016-5085(17)30333.
    PubMed     Text format     Abstract available

  20. GARIN E, Pallard X, Edeline J
    Does Y90 Radioembolization Prolong Overall Survival Compared With Chemoembolization in Patients With Hepatocellular Carcinoma?
    Gastroenterology. 2017 Mar 31. pii: S0016-5085(17)30222.
    PubMed     Text format    

  21. YOUNG S, Golzarian J
    Regarding: Y90 Radioembolization Significantly Prolongs Time to Progression Compared With Chemoembolization in Patients With Hepatocellular Carcinoma.
    Gastroenterology. 2017 Mar 31. pii: S0016-5085(17)30225.
    PubMed     Text format    

  22. DURAN R, Deltenre P, Denys A
    RE: Y90 Radioembolization Significantly Prolongs Time to Progression Compared With Chemoembolization in Patients With Hepatocellular Carcinoma.
    Gastroenterology. 2017 Apr 1. pii: S0016-5085(17)30224.
    PubMed     Text format    

  23. PAN LH, Zhao C, Ma YL
    Is Y90 Radioembolization Superior or Comparable to Transarterial Chemoembolization for Treating Hepatocellular Carcinoma?
    Gastroenterology. 2017 Apr 3. pii: S0016-5085(17)30221.
    PubMed     Text format    

  24. MANCINA RM, Dongiovanni P, Petta S, Pingitore P, et al
    The MBOAT7-TMC4 Variant rs641738 Increases Risk of Nonalcoholic Fatty Liver Disease in Individuals of European Descent.
    Gastroenterology. 2016;150:1219-1230.
    PubMed     Text format     Abstract available

  25. WANG L, Yin J, Wang X, Shao M, et al
    C-type Lectin-like Receptor 2 Suppresses AKT Signaling and Invasive Activities of Gastric Cancer Cells by Blocking Expression of PI3K Subunits.
    Gastroenterology. 2016 Feb 5. pii: S0016-5085(16)00133.
    PubMed     Text format     Abstract available


    Gut

  26. HANIN G, Yayon N, Tzur Y, Haviv R, et al
    miRNA-132 induces hepatic steatosis and hyperlipidaemia by synergistic multitarget suppression.
    Gut. 2017 Apr 5. pii: gutjnl-2016-312869. doi: 10.1136/gutjnl-2016-312869.
    PubMed     Text format     Abstract available


    Hepatology

  27. SORIANO G, Bajaj JS
    Grading the range of hepatic encephalopathy from overt to covert: Animals to the Rescue!
    Hepatology. 2017 Mar 30. doi: 10.1002/hep.29186.
    PubMed     Text format    

  28. SORIA A, Fabbiani M, Lapadula G, Gori A, et al
    Unexpected viral relapses in HCV-infected patients diagnosed with hepatocellular carcinoma during treatment with DAAs.
    Hepatology. 2017 Mar 30. doi: 10.1002/hep.29181.
    PubMed     Text format    

  29. LIU P, Ge M, Hu J, Li X, et al
    A functional mTORC1 signaling is indispensable for c-Myc driven hepatocarcinogenesis.
    Hepatology. 2017 Mar 30. doi: 10.1002/hep.29183.
    PubMed     Text format     Abstract available

  30. TOHME S, Yazdani HO, Liu Y, Loughran P, et al
    Hypoxia mediates mitochondrial biogenesis in hepatocellular carcinoma to promote tumor growth via HMGB1 and TLR9 interaction.
    Hepatology. 2017 Mar 30. doi: 10.1002/hep.29184.
    PubMed     Text format     Abstract available

  31. KIM KH, Choi S, Zhou Y, Kim EY, et al
    Hepatic FXR/SHP Axis Modulates Systemic Glucose and Fatty Acid Homeostasis in Aged Mice.
    Hepatology. 2017 Apr 5. doi: 10.1002/hep.29199.
    PubMed     Text format     Abstract available

  32. ZHANG H, Li ZL, Xing H, Wu MC, et al
    Hepatocellular Carcinoma Surveillance: Sometimes Just Specialists' Incidental Behavior?
    Hepatology. 2017 Apr 7. doi: 10.1002/hep.29200.
    PubMed     Text format    


    J Gastroenterol

  33. CAI X, Hayashi S, Fang C, Hao S, et al
    Pu'erh tea extract-mediated protection against hepatosteatosis and insulin resistance in mice with diet-induced obesity is associated with the induction of de novo lipogenesis in visceral adipose tissue.
    J Gastroenterol. 2017 Mar 31. doi: 10.1007/s00535-017-1332.
    PubMed     Text format     Abstract available


    J Hepatol

  34. KIM JY, Park KJ, Hwang JY, Kim GH, et al
    Activating Transcription Factor 3 Is a Target Molecule Linking Hepatic Steatosis to Impaired Glucose Homeostasis.
    J Hepatol. 2017 Mar 29. pii: S0168-8278(17)30187.
    PubMed     Text format     Abstract available


    J Pediatr Surg

  35. COUGHLIN MA, Werner NL, Gajarski R, Gadepalli S, et al
    Prenatally diagnosed severe CDH: mortality and morbidity remain high.
    J Pediatr Surg. 2016;51:1091-5.
    PubMed     Text format     Abstract available


    Lancet Oncol

  36. NABAVIZADEH N, Mitin T, Dawson LA, Hong TS, et al
    Stereotactic body radiotherapy for patients with hepatocellular carcinoma and intermediate grade cirrhosis.
    Lancet Oncol. 2017;18:e192.
    PubMed     Text format    

  37. GRANITO A, Bolondi L
    Stereotactic body radiotherapy for patients with hepatocellular carcinoma and intermediate grade cirrhosis - Authors' reply.
    Lancet Oncol. 2017;18:e193.
    PubMed     Text format    


    PLoS One

  38. PAN C, Wang X, Shi K, Zheng Y, et al
    MiR-122 Reverses the Doxorubicin-Resistance in Hepatocellular Carcinoma Cells through Regulating the Tumor Metabolism.
    PLoS One. 2016;11:e0152090.
    PubMed     Text format     Abstract available

  39. MOUZAKI M, Wang AY, Bandsma R, Comelli EM, et al
    Bile Acids and Dysbiosis in Non-Alcoholic Fatty Liver Disease.
    PLoS One. 2016;11:e0151829.
    PubMed     Text format     Abstract available

  40. ARAGONES G, Auguet T, Berlanga A, Guiu-Jurado E, et al
    Increased Circulating Levels of Alpha-Ketoglutarate in Morbidly Obese Women with Non-Alcoholic Fatty Liver Disease.
    PLoS One. 2016;11:e0154601.
    PubMed     Text format     Abstract available


    Radiology

  41. CHEN R, Li J, Zhou X, Liu J, et al
    Fructose-1,6-Bisphosphatase 1 Reduces 18F FDG Uptake in Hepatocellular Carcinoma.
    Radiology. 2017 Apr 6:161607. doi: 10.1148/radiol.2017161607.
    PubMed     Text format     Abstract available


    Transplant Proc

  42. GARCIA-PAJARES F, Penas-Herrero I, Sanchez-Ocana R, Torrres-Yuste R, et al
    Metabolic Syndrome After Liver Transplantation: Five-Year Prevalence and Risk Factors.
    Transplant Proc. 2016;48:3010-3012.
    PubMed     Text format     Abstract available

  43. SULIK-TYSZKA B, Figiel W, Krawczyk M, Wroblewska M, et al
    Invasive Aspergillosis of the Stomach and Co-infection With Candida krusei in a Patient With Terminal Liver Failure: A Case Report.
    Transplant Proc. 2016;48:3149-3152.
    PubMed     Text format     Abstract available

  44. GOJOWY D, Adamczak M, Dudzicz S, Gazda M, et al
    High Frequency of Arterial Hypertension in Patients After Liver Transplantation.
    Transplant Proc. 2016;48:1721-4.
    PubMed     Text format     Abstract available

  45. PEREIRA S, Cruz CM, Soares M, Gandara J, et al
    Histology Utility in Liver Graft Surveillance: What About Normal Liver Tests?
    Transplant Proc. 2016;48:2344-2347.
    PubMed     Text format     Abstract available

  46. ANNUNZIATA TB, Paulino K, Fernandes R, Bento G, et al
    Impact of Model for End-stage Liver Disease Score in Post-Liver Transplantation Prognosis.
    Transplant Proc. 2016;48:2348-2351.
    PubMed     Text format     Abstract available

  47. MARQUES DM, Teixeira HR, Lopes AR, Martins-Pedersoli TA, et al
    Sleep Quality Assessment and Daytime Sleepiness of Liver Transplantation Candidates.
    Transplant Proc. 2016;48:2356-2360.
    PubMed     Text format     Abstract available

  48. REAL C, Sobreira Fernandes D, Sa Couto P, Correia de Barros F, et al
    Survival Predictors in Liver Transplantation: Time-Varying Effect of Red Blood Cell Transfusion.
    Transplant Proc. 2016;48:3303-3306.
    PubMed     Text format     Abstract available

  49. BAKULA A, Pawlowska J, Niewiadomska O, Jankowska I, et al
    Liver Transplantation in Polish Children With alpha1-Antitrypsin Deficiency: A Single-Center Experience.
    Transplant Proc. 2016;48:3323-3327.
    PubMed     Text format     Abstract available

  50. MIZUNO Y, Ito S, Hattori K, Nagaya M, et al
    Changes in Muscle Strength and Six-Minute Walk Distance Before and After Living Donor Liver Transplantation.
    Transplant Proc. 2016;48:3348-3355.
    PubMed     Text format     Abstract available

  51. LEE CF, Wang YC, Cheng CH, Wu TH, et al
    Application of CD8+ Cells Count as a Guide of Immunosuppressive Regimen Introduction for Very Sick Patients Undergoing Liver Transplantation.
    Transplant Proc. 2016;48:3356-3361.
    PubMed     Text format     Abstract available

  52. MOLINA AR, Vilchez AR, Dominguez MB, Garcia AN, et al
    Influence of Body Mass Index on Venous Thrombotic Complications of Liver Transplants.
    Transplant Proc. 2016;48:3017-3020.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Liver Diseases is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: